Endothelial Protein C Receptor
"Endothelial Protein C Receptor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glycosylated transmembrane receptor for PROTEIN C that is highly expressed by endothelial cells on the surface of large blood vessels in the heart and lungs. It facilitates protein C activation by the THROMBIN and THROMBOMODULIN complex in blood coagulation.
Descriptor ID |
D000074283
|
MeSH Number(s) |
D12.776.395.550.294 D12.776.543.550.294 D12.776.543.750.045
|
Concept/Terms |
Endothelial Protein C Receptor- Endothelial Protein C Receptor
- Protein C Receptor
- Receptor, Protein C
- PROCR
- Antigens, CD201
- CD201 Antigens
- CD201 Antigen
- Antigen, CD201
- EPCR
|
Below are MeSH descriptors whose meaning is more general than "Endothelial Protein C Receptor".
Below are MeSH descriptors whose meaning is more specific than "Endothelial Protein C Receptor".
This graph shows the total number of publications written about "Endothelial Protein C Receptor" by people in this website by year, and whether "Endothelial Protein C Receptor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 0 | 2 | 2 |
2009 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endothelial Protein C Receptor" by people in Profiles.
-
Dysregulation of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis. J Rheumatol. 2012 Mar; 39(3):510-5.
-
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis. Rheumatology (Oxford). 2009 May; 48(5):513-9.
-
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study. Gynecol Oncol. 2007 Sep; 106(3):596-603.
-
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study. Gynecol Oncol. 2007 May; 105(2):508-16.
-
Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice. Blood. 2007 Feb 01; 109(3):1003-9.
-
Bimodal distribution of soluble endothelial protein C receptor levels in healthy populations. J Thromb Haemost. 2003 Apr; 1(4):855-6.